Skip to main content

Advertisement

Log in

Chemoprevention of colorectal cancer in ulcerative colitis

  • Original Article
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

Patients with ulcerative colitis (UC) are at greater risk of developing colorectal cancer (CRC) than the general population. Both duration and extent of UC are important risk factors for CRC, as is the presence of primary sclerosing cholangitis, family history of CRC, and (in some studies) early age at diagnosis of UC. Efforts to reduce this risk have focused on colonoscopic surveillance as the best alternative to the more definitive, but less appealing, approach of prophylactic colectomy. However, spurred on by findings in the sporadic CRC literature, there has been a growing interest in a possible role for chemoprevention of CRC in patients with UC.

Empirical studies

Published evidence to date indicates that 5-aminosalicylic acid agents are protective against the development of dysplasia and CRC. Oral, but not topical, steroids also appear to be chemoprotective, but their chronic use cannot be recommended for this indication. Ursodeoxycholic acid has been shown to reduce the risk of neoplasia in UC patients with primary sclerosing cholangitis. Evidence suggests, but does not prove, that folic acid is chemopreventive in patients with UC. Further studies are needed to fully define the chemoprotective role of these and other agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crohn BB, Rosenberg H (1925) The sigmoidoscopic picture of chronic ulcerative colitis. Am J Med Sci 170:220–228

    Google Scholar 

  2. Gyde S, Prior P, Dew MJ, Saunders V, Waterhouse JA, Allan RN (1982) Mortality in ulcerative colitis. Gastroenterology 83:36–43

    CAS  PubMed  Google Scholar 

  3. Itzkowitz SH (1997) Inflammatory bowel disease and cancer. Gastroenterol Clin North Am 26:129–139

    CAS  PubMed  Google Scholar 

  4. Ransohoff DF (1988) Colon cancer in ulcerative colitis. Gastroenterology 94:1089–1091

    CAS  PubMed  Google Scholar 

  5. Eaden JA, Abrams KR, Mayberry JF (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48:526–535

    Article  CAS  PubMed  Google Scholar 

  6. Brentnall TA, Haggitt RC, Rabinovitch PS, et al (1996) Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis. Gastroenterology 110:331–338

    CAS  PubMed  Google Scholar 

  7. Shetty K, Rybicki L, Brzezinski A, Carey WD, Lashner BA (1999) The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol 94:1643–1649

    CAS  PubMed  Google Scholar 

  8. Broome U, Lofberg R, Veress B, Eriksson LS (1995) Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential. Hepatology 22:1404–1408

    CAS  PubMed  Google Scholar 

  9. Loftus EV Jr, Sandborn WJ, Tremaine WJ, et al (1996) Risk of colorectal neoplasia in patients with primary sclerosing cholangitis. Gastroenterology 110:432–440

    PubMed  Google Scholar 

  10. Gurbuz AK, Giardiello FM, Bayless TM (1995) Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum 38:37–41

    CAS  PubMed  Google Scholar 

  11. Kornfeld D, Ekbom A, Ihre T (1997) Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based study. Gut 41:522–525

    CAS  PubMed  Google Scholar 

  12. Askling J, Dickman PW, Karlen P, et al (2001) Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology 120:1356–1362

    Article  CAS  PubMed  Google Scholar 

  13. Nuako KW, Ahlquist DA, Mahoney DW, Schaid DJ, Siems DM, Lindor NM (1998) Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case-control study. Gastroenterology 115:1079–1083

    CAS  PubMed  Google Scholar 

  14. Bertone ER, Giovannucci EL, King NW Jr, Petto AJ, Johnson LD (1998) Family history as a risk factor for ulcerative colitis-associated colon cancer in cotton-top tamarin. Gastroenterology 114:669–674

    CAS  PubMed  Google Scholar 

  15. Lashner BA, Heidenreich PA, Su GL, Kane SV, Hanauer SB (1989) Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology 97:255–259

    CAS  PubMed  Google Scholar 

  16. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323:1228–1233

    CAS  PubMed  Google Scholar 

  17. Gilat T, et al (1988) Colorectal cancer in patients with ulcerative colitis. A population study in central Israel. Gastroenterology 94:870–877

    CAS  PubMed  Google Scholar 

  18. Greenstein AJ, Sachar DB, Smith H, et al (1979) Cancer in universal and left-sided ulcerative colitis: factors determining risk. Gastroenterology 77:290–294

    CAS  PubMed  Google Scholar 

  19. Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses AH Jr, Greenstein AJ (1991) Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32:167–169

    CAS  PubMed  Google Scholar 

  20. Collins RH Jr, Feldman M, Fordtran JS (1987) Colon cancer, dysplasia, and surveillance in patients with ulcerative colitis. A critical review. N Engl J Med 316:1654–1658

    PubMed  Google Scholar 

  21. Connell WR, Lennard-Jones JE, Williams CB, Talbot IC, Price AB, Wilkinson KH (1994) Factors affecting the outcome of endoscopic surveillance for cancer in ulcerative colitis. Gastroenterology 107:934–944

    CAS  PubMed  Google Scholar 

  22. Choi PM, Nugent FW, Schoetz DJ Jr, Silverman ML, Haggitt RC (1993) Colonoscopic surveillance reduces mortality from colorectal cancer in ulcerative colitis. Gastroenterology 105:418–424

    CAS  PubMed  Google Scholar 

  23. Lennard-Jones JE, Melville DM, Morson BC, Ritchie JK, Williams CB (1990) Precancer and cancer in extensive ulcerative colitis: findings among 401 patients over 22 years. Gut 31:800–806

    CAS  PubMed  Google Scholar 

  24. Provenzale D, Wong JB, Onken JE, Lipscomb J (1998) Performing a cost-effectiveness analysis: surveillance of patients with ulcerative colitis. Am J Gastroenterol 93:872–880

    Google Scholar 

  25. Karlen P, Kornfeld D, Brostrom O, Lofberg R, Persson PG, Ekbom A (1998) Is colonoscopic surveillance reducing colorectal cancer mortality in ulcerative colitis? A population based case control study. Gut 42:711–714

    CAS  PubMed  Google Scholar 

  26. Eaden J, Abrams K, Ekbom A, Jackson E, Mayberry J (2000) Colorectal cancer prevention in ulcerative colitis: a case-control study. Aliment Pharmacol Ther 14:145–153

    Article  CAS  Google Scholar 

  27. Giovannucci E (1999) The prevention of colorectal cancer by aspirin use. Biomed Pharmacother 53:303–308

    Article  CAS  PubMed  Google Scholar 

  28. Giovannucci E, Egan KM, Hunter DJ, et al (1995) Aspirin and the risk of colorectal cancer in women. N Engl J Med 333:609–614

    CAS  PubMed  Google Scholar 

  29. Giovannucci E, Rimm EB, Stampfer MJ, Colditz GA, Ascherio A, Willett WC (1994) Aspirin use and the risk for colorectal cancer and adenoma in male health professionals. Ann Intern Med 121:241–246

    CAS  PubMed  Google Scholar 

  30. Smalley W, Ray WA, Daugherty J, Griffin MR (1999) Use of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer: a population-based study. Arch Intern Med 159:161–166

    CAS  PubMed  Google Scholar 

  31. Giovannucci E, Stampfer MJ, Colditz GA, et al (1998) Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 129:517–524

    CAS  PubMed  Google Scholar 

  32. Giovannucci E, Stampfer MJ, Colditz GA, et al (1993) Folate, methionine, and alcohol intake and risk of colorectal adenoma. J Natl Cancer Inst 85:875–884

    CAS  PubMed  Google Scholar 

  33. Baron JA, Beach M, Mandel JS, et al (1999) Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med 340:101–107

    CAS  PubMed  Google Scholar 

  34. Giardiello FM, Hamilton SR, Krush AJ, et al (1993) Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 328:1313–1316

    CAS  PubMed  Google Scholar 

  35. Bansal P, Sonnenberg A (1996) Risk factors of colorectal cancer in inflammatory bowel disease. Am J Gastroenterol 91:44–48

    Google Scholar 

  36. Agoff SN, Brentnall TA, Crispin DA, et al (2000) The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157:737–7345

    CAS  PubMed  Google Scholar 

  37. Lashner BA, Provencher KS, Seidner DL, Knesebeck A, Brzezinski A (1997) The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology 112:29–32

    CAS  PubMed  Google Scholar 

  38. Pinczowski D, Ekbom A, Baron J, Yuen J, Adami HO (1994) Risk factors for colorectal cancer in patients with ulcerative colitis: a case-control study. Gastroenterology 107:117–120

    CAS  PubMed  Google Scholar 

  39. Moody GA, Jayanthi V, Probert CS, MacKay H, Mayberry JF (1996) Long-term therapy with sulphasalazine protects against colorectal cancer in ulcerative colitis: a retrospective study of colorectal cancer risk and compliance with treatment in Leicestershire. Eur J Gastroenterol Hepatol 8:1179–1183

    CAS  PubMed  Google Scholar 

  40. Tung BY, Emond MJ, Haggitt RC, et al (2001) Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med 134:89–95

    CAS  PubMed  Google Scholar 

  41. Bus PJ, Nagtegaal ID, Verspaget HW, et al (1999) Mesalazine-induced apoptosis of colorectal cancer: on the verge of a new chemopreventive era? Aliment Pharmacol Ther 13:1397–1402

    Article  CAS  PubMed  Google Scholar 

  42. Butterworth CE Jr, Hatch KD, Gore H, Mueller H, Krumdieck CL (1982) Improvement in cervical dysplasia associated with folic acid therapy in users of oral contraceptives. Am J Clin Nutr 35:73–82

    CAS  PubMed  Google Scholar 

  43. Heimburger DC, Alexander CB, Birch R, Butterworth CE Jr, Bailey WC, Krumdieck CL (1988) Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial. JAMA 259:1525–1530

    CAS  PubMed  Google Scholar 

  44. Freudenheim JL, Graham S, Marshall JR, Haughey BP, Cholewinski S, Wilkinson G (1991) Folate intake and carcinogenesis of the colon and rectum. Int J Epidemiol 20:368–374

    CAS  PubMed  Google Scholar 

  45. Biasco G, Zannoni U, Paganelli GM, et al (1997) Folic acid supplementation and cell kinetics of rectal mucosa in patients with ulcerative colitis. Cancer Epidemiol Biomarkers Prev 6:469–471

    CAS  PubMed  Google Scholar 

  46. Hill MJ, Melville DM, Lennard-Jones JE, Neale K, Ritchie JK (1987) Faecal bile acids, dysplasia, and carcinoma in ulcerative colitis. Lancet 2:185–186

    CAS  PubMed  Google Scholar 

  47. Nagengast FM, Grubben MJ, van Munster IP (1995) Role of bile acids in colorectal carcinogenesis. Eur J Cancer 31A:1067–1070

    Article  CAS  PubMed  Google Scholar 

  48. Martinez JD, Stratagoules ED, LaRue JM, et al (1998) Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31:111–118

    CAS  PubMed  Google Scholar 

  49. Ochsenkuhn T, Bayerdorffer E, Meining A, et al (1999) Colonic mucosal proliferation is related to serum deoxycholic acid levels. Cancer 85:1664–1669

    Article  CAS  PubMed  Google Scholar 

  50. Rodrigues CM, Kren BT, Steer CJ, Setchell KD (1995) The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation. Gastroenterology 109:1835–1844

    CAS  PubMed  Google Scholar 

  51. Lewis JD (2001) Ursodiol prevents UC-associated CRC. Gastroenterology 121:491–492

    CAS  PubMed  Google Scholar 

  52. Newmarck H, Wargovich M, Bruce W (1984) Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst 72:1323–1325

    PubMed  Google Scholar 

  53. Pence BC, Dunn DM, Zhao C, Landers M, Wargovich MJ (1995) Chemopreventive effects of calcium but not aspirin supplementation in cholic acid-promoted colon carcinogenesis: correlation with intermediate endpoints. Carcinogenesis 16:757–765

    CAS  PubMed  Google Scholar 

  54. Pence BC (1993) Role of calcium in colon cancer prevention: experimental and clinical studies. Mutat Res 290:87–95

    CAS  PubMed  Google Scholar 

  55. Pence BC, Buddingh F (1988) Inhibition of dietary fat-promoted colon carcinogenesis in rats by supplemental calcium or vitamin D3. Carcinogenesis 9:187–190

    CAS  PubMed  Google Scholar 

  56. Martinez ME, Willett WC (1998) Calcium, vitamin D, and colorectal cancer: a review of the epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 7:163–168

    CAS  PubMed  Google Scholar 

  57. Bergsma-Kadijk J, van't Veer P, Kampman E, Burema J (1996) Calcium does not protect against colorectal neoplasia. Epidemiology 7:590–597

    CAS  Google Scholar 

  58. Holt PR, Atillasoy EO, Gilman J, et al (1998) Modulation of abnormal colonic epithelial cell proliferation and differentiation by low-fat dairy foods: a randomized controlled trial. JAMA 280:1074–1079

    CAS  PubMed  Google Scholar 

  59. Rooney P, Clarke P, Gifford K-A, et al (1993) Identification of high and low risk groups of colorectal cancer using rectal mucosal crypt cell production rate (CCPR). Br J Cancer 68:172–175

    CAS  PubMed  Google Scholar 

  60. Bostick RM, Boldt M, Darif M, Wood JR, Overn P, Potter JD (1997) Calcium and colorectal epithelial cell proliferation in ulcerative colitis. Cancer Epidemiol Biomarkers Prev 6:1021–1027

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This research was supported in part by grants from the National Cancer Institute (RO1 CA81363) and the Chemotherapy Foundation (S.H.I.). T.A.U. is the recipient of a Career Development Award from the Crohn's and Colitis Foundation of America, and a Wilson-Cooke Award from the American Society of Gastrointestinal Endoscopy.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Steven H. Itzkowitz.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Croog, V.J., Ullman, T.A. & Itzkowitz, S.H. Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis 18, 392–400 (2003). https://doi.org/10.1007/s00384-002-0476-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-002-0476-6

Keywords

Navigation